Sharon F. Mcgee
Ottawa, ON K1H8M5, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
The Rethinking Clinical Trials (REaCT) Program: A Pragmatic Research Strategy to Improve Cancer Care for Patients, Caregivers, and Healthcare Systems.
Journal: Current oncology (Toronto, Ont.)
Published: June 27, 2025
Authors' Reply: Equity-Centered Optimization of Virtual Cancer Survivorship Care.
Journal: Journal of medical Internet research
Published: June 21, 2025
Patient perceptions around the use of clinico-pathologic and genomic tools in the management of early breast cancer.
Journal: Breast cancer research and treatment
Published: March 21, 2025
A Multicenter Physician Survey Evaluating the Use of Ki-67 in Breast Cancer Management in Canada.
Journal: Biomedicines
Published: October 04, 2024
The Landscape of Breast Cancer Molecular and Histologic Subtypes in Canada.
Journal: Current oncology (Toronto, Ont.)
Published: August 09, 2024
Optimizing Virtual Follow-Up Care: Realist Evaluation of Experiences and Perspectives of Patients With Breast and Prostate Cancer.
Journal: Journal of medical Internet research
Published: August 06, 2024
A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: June 10, 2024
The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care.
Journal: Current oncology (Toronto, Ont.)
Published: February 06, 2024
Development and application of a weighted change score to evaluate interventions for vasomotor symptoms in patients with breast cancer using regression trees: a cohort study.
Journal: Breast cancer research and treatment
Published: January 26, 2024
Perspectives on shorter durations of anti-HER2 therapy in early-stage HER2-positive breast cancer: a patient survey.
Journal: Breast cancer research and treatment
Published: November 14, 2023
Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective.
Journal: Current oncology (Toronto, Ont.)
Published: October 30, 2023
Last Updated: 09/26/2026